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Abstracts 
Objective: To investigate the effect of Bacailin on inflammatory mediator levels and microcirculation disturbance in severe 
acute pancreatitis (SAP) rats and explore its therapeutic mechanism on this disease. 
Methods: SAP model rats were randomly divided into model control group and Baicalin treated group, 45 rats in each 
group. The same number of normal rats were included in sham-operated group. These groups were further subdivided into 
3 h, 6 h and 12 h subgroups, respectively (15 rats in each subgroup). At 3, 6 and 12 hours after operation, rats were killed to 
conduct the following experiments: (1) to examine the mortality rates of rats, the ascites volume and pancreatic 
pathological changes in each group; (2) to determine the contents of amylase, PLA2, TXB2, PGE2, PAF and IL-1β in blood 
as well as the changes in blood viscosity. 
Results: (1) Compared to model control group, treatment with Baicalin is able to improve the pathological damage of the 
pancreas, lower the contents of amylase and multiple inflammatory mediators in blood, decrease the amount of ascitic fluid 
and reduce the mortality rates of SAP rats (P<0.01, P<0.01 or P<0.001); (2) at 3 hours after operation, the low-shear whole 
blood viscosity (1/s)(mPa.s) in Baicalin treated group was significantly lower than that in model control group (P<0.01); at 
12 hours after operation, both the high-shear (200/s) (mPa.s) and low-shear  whole blood viscosity (1/s) (mPa.s) in 
Baicalin treated group were also significantly lower than those in model control group (P<0.01 for all). 
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Conclusion: Baicalin, as a new drug, has good prospects in the treatment of SAP since it can exert therapeutic effects on 
this disease through inhibiting the production of inflammatory mediators, lowering blood viscosity, improving 
microcirculation and mitigating the pathological damage of the pancreas. 
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1. Introduction 
In recent years, the roles of microcirculation disturbance in the pathogenesis of severe acute pancreatitis (SAP) have 
attracted extensive attention [1,2]. Microcirculation disturbance refers to the morphological alterations and functional 
disturbance of blood vessels or blood flow at microcirculatory level. Hemorheological changes are one of the most 
important factors that can induce microcirculation disturbance. Even in the early stage of SAP, an obvious disturbance of 
pancreatic microcirculation is present. Therefore, it has important significance to improve pancreatic microcirculation in 
the treatment of SAP [3]. In the present study, we investigate the effect of Baicalin on inflammatory mediator levels and 
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microcirculation disturbance in SAP rats and explore its therapeutic mechanism, thereby providing a theoretical basis for 
treating this disease with Baicalin. 
 
2 Materials and methods  
2.1 Main materials: Clean grade healthy male Sprague-Dawley (SD) rat in 250－300 g of body weight purchased from the 
Experimental Animal Center of Medical School, Zhejiang University,China. Sodium taurocholate and sodium pentobarbital 
purchased from USA Sigma Company; Octreotide purchased from Swiss pharmaceutical company Novartis; 1% Baicalin 
injection (China national invention patent number ZL200310122673.6) prepared by the first author with 310 mmol/L 
osmotic pressure; The full automatic biochemical analyzer was used to determine the plasma amylase level (unit of 
measure: U/L); Thromoboxane B2 immunoassay kit (catalog No.DE0700; unit of measure:pg/mL) and PGE2 immunoassay 
kit (catalog No.DE0100; unit of measure:pg/mL) were purchased from the RδD system Ins (USA). PAF immunoassay kit 
(unit of measure:ng/L) and IL-1β immunoassay kit (unit of measure:ng/L) were purchased from the Hangzhou Haotian 
Biotechnology Co. LTD (China). These assays were conducted according to the instructions provided in the kits. Blood 
viscosity was determined using SA-6000 automatic hemorheological testing instrument, which was provided by the Beijing 
Success Technology Development Co., LTD (China). 
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2.2Methods 
2.2.1. Animal grouping: Ninety SAP model rats were prepared with 3.5% sodium taurocholate and randomly divided into 
model control group and Baicalin treated group, 45 rats in each group. The same number of normal rats were included in 
sham-operated group, which only received laparotomy. These groups were further subdivided into 3 h, 6 h and 12 h 
subgroups, respectively (15 rats in each subgroup). 
2.2.2 Preparation of SAP model and procedure of treatment: Fast but water restraint was imposed on all rat groups 12h 
prior to the operation. The rats were anesthetized by intraperitoneal injection of 2% sodium pentobarbital (0.25ml/100g) 
after which lay and fixed the rats, and performed the routine shaving, disinfection and draping. First established the right 
external jugular vein transfusion passage used the microinfusion pump for continuous transfusion (1ml/h/100g) and then 
used 3.5% sodium taurocholate to prepare SAP model. In model control group: After entering abdomen via median 
epigastrium incision, confirmed the bile-pancreatic duct and hepatic hilus common hepatic duct, disclosed the pancreas, 
identified the duodenal papilla inside the duodenum duct wall, and then used a No.5 needle to drill a hole in the 
mesenterium avascular area. After inserting a segmental eqidural catheter into the duodenum cavity via the hole, inserted 
the bile-pancreatic duct toward the direction of papilla in a retrograde way, used the microvascular clamp to nip the duct 
head temporarily and meanwhile used another microvascular clamp to temporarily occlude the common hepatic duct at the 
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confluence of hepatic duct. After connecting the anaesthetic tube end with the transfusion converter, transfused 3.5% 
sodium taurocholate (0.1ml/100g) by retrograde transfusion via the microinjection pump (made by Zhejiang University) at 
the speed of 0.2ml/minute. Stayed for 4 to 5 minutes after injection and removed the microvascular clamp and epidural 
catheter. After checking for bile leakage, sutured the hole in the duodenum lateral wall. Used the disinfected cotton ball to 
absorb up the anaesthetic in the abdominal cavity and close the abdomen. Sham-operated group after receiving abdomen 
opening was only performed pancreas and duodenum turning over and finally abdomen closing. In Baicalin treated group: 
The animal experiments of 1% Baicalin injection have been completed including the acute toxicity test and SAP rat 
treatment by small, middle and large dose. The large dose can achieve the best therapeutic effect (dose is 10mg/h/100g) and 
the dosage referred to the result of the previous preliminary experiment. 10 minutes after successful modeling, Baicalin 
treatment group was first injected 5% Baicalin injection 10mg/100g via external jugular vein passage followed by 
continuous intravenous administration (10mg/h/100g) by microinfusion pump; The dosage of Baicalin has been proved as 
effective dosage in the previous preliminary experiment. Both of sham-operated group and model control group were 
injected saline of equivalent volume at the corresponding time points after operation. 
2.2.3. Parameters determined: at 3, 6 and 12 hours after operation, the mortality rates of rats in each group were observed. 
These rats were then killed and subjected to examination of the ascites volume and the pathological changes of the pancreas 
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as well as the score of pathological changes under light microscopy [4]. The blood was then collected to determine the 
contents of amylase, TXB2, PGE2, PAF and IL-1β in blood. At 3 and 12 hours after operation, blood viscosity, including 
high-shear whole blood viscosity (200/s) (mPa.s), whole blood viscosity (30/s) (mPa.s) and low-shear whole blood 
viscosity (1 or 5/s) (mPa.s), were measured. 
2.2.4. Statistical analysis: all data were analyzed using the SPSS13.0 software. Because the comparisons of the 
pathological scores of the pancreas, the contents of PAF, amylase, TXB2, PGE2, PAF and IL-1β in blood as well as the 
ascites/body weight ratio belong to non-parameter test, the Kruskal-Wallis test was used for multiple comparisons among 
the three groups. The Mann-Whitney U test was used for pair-wise comparisons. The correlations among each parameter 
were analyzed using the Spearman correlation test. Since all four blood viscosity parameters meet the normal distribution 
and should be subjected to parameter test, the ANOVA test was used for multiple comparisons of these parameters among 
the three groups. The Bonferroni test was used for pair-wise comparisons. The correlations among each parameter were 
analyzed using the Spearman correlation test. Statistical significance was concluded if the P value was less than or equal to 
0.05. 
 
3 Results 
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3.1. Comparison of mortality rate: in sham-operated group, no rats died at 3, 6 and 12 hours after operation. In model 
control group, one and four rats died at 6 and 12 hours after operation, respectively. In Baicalin treated group, one rat died 
at 12 hours after operation. At 12 hours after operation, the mortality rate of rats in sham-operated group and treated group 
were significantly lower than that in model control group (P = 0.05). 
3.2. Comparison of pathological scores of the pancreas, ascites volume and contents of inflammatory mediators in 
blood: the results were shown in Tables 1 and 2. 
3.2.1. At three hours after operation: the pathological scores of the pancreas, the contents of PAF, amylase, TXB2, PGE2 
and IL-1β in blood as well as the ascites/body weight ratio in sham-operated group were significantly lower than those in 
model control group and Baicalin treated group (P<0.001 for all). The contents of plasma amylase and the ascites/body 
weight ratio in treated group were significantly lower than those in model control group (P<0.005). Besides, the content of 
serum IL-1β in the former group was also significantly lower than that in the latter group (P<0.01). 
3.2.2. At six hours after operation: the pathological scores of the pancreas, the contents of PLA2, PAF, amylase, TXB2 and 
PGE2 in blood as well as the ascites/body weight ratio in sham-operated group were significantly lower than those in model 
control group (P<0.001 for all). The pathological scores of the pancreas, the contents of PLA2, PAF, amylase, TXB2, PGE2 
and IL-1β in blood as well as the ascites/body weight ratio in sham-operated group were also significantly lower than those 
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in Baicalin treated group (P<0.001 for all). The content of TXB2 in blood in treated group was significantly lower than that 
in model control group (P<0.05). Besides, the ascites/body weight ratio and the content of TXB2 in blood in the former 
group were also significantly lower than those in model control group (P<0.001). 
3.2.3. At twelve hours after operation: the pathological scores of the pancreas, the contents of PLA2, PAF, amylase, TXB2, 
PGE2 and IL-1β in blood as well as the ascites/body weight ratio in sham-operated group were significantly lower than 
those in model control group (P<0.001 for all). The pathological scores of the pancreas, the contents of PLA2, PAF, amylase, 
TXB2, and PGE2 in blood as well as the ascites/body weight ratio in sham-operated group were also significantly lower 
than those in Baicalin treated group (P<0.001 for all). The pathological scores of the pancreas, the contents of amylase and 
PLA2 as well as the ascites/body weight ratio in treated group were significantly lower than those in model control group 
(P<0.01, P<0.01, P<0.001 and P<0.05, respectively). 
3.3. Correlation analysis results (Spearman correlation): 
3.3.1. Model control group: at 12 hours after operation, a negative correlation between the contents of amylase and PGE2 
in blood was noted (R=-0.678, P<0.05). 
3.3.2. Sham-operated group: at 12 hours after operation, a positive correlation between the content of amylase in blood 
and the ascites/body weight ratio was noted (R=0.533, P<0.05). 
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3.3.3. Baicalin treated group: at 6 hours after operation, a positive correlation between the pathological scores of the 
pancreas and the content of amylase in blood was noted (R=0.579, P<0.05); at 12 hours after operation, a positive 
correlation between the content of PAF in blood and the ascites/body weight ratio was observed (R=0.618, P<0.05). 
3.4. Comparison of blood viscosity parameters: the results were shown in Table 3. 
3.4.1. At three hours after operation: the low-shear whole blood viscosity in model control group was significantly 
higher than that in sham-operated group (P<0.01); the whole blood viscosity and low-shear  whole blood viscosity (5 or 
1/s) (mPa.s) in model control group were significantly higher than those in sham-operated group (P<0.001). The whole 
blood viscosity (30/s) (mPa.s) and low-shear whole blood viscosity (1/s) (mPa.s) in treated group were significantly higher 
than those in sham-operated group (P<0.05) while the low-shear whole blood viscosity (1/s) (mPa.s) in treated group was 
significantly lower than that in model control group (P<0.01). 
3.4.2. At twelve hours after operation: the high-shear whole blood viscosity (200/s) (mPa.s), whole blood viscosity (30/s) 
(mPa.s) and low-shear whole blood viscosity (1/s) (mPa.s) in model control group were significantly higher than those in 
sham-operated group (P<0.001). The high-shear whole blood viscosity (200/s) (mPa.s) and low-shearwhole blood viscosity  
(5/s) (mPa.s) in treated group were significantly higher than those in sham-operated group (P<0.01 and P<0.05, 
respectively). The high-shear whole blood viscosity (200/s) (mPa.s) and low-shear whole blood viscosity (1/s) (mPa.s) in 
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treated group were significantly lower than those in model control group (P<0.01).  
3.5. Gross pathological changes and pathological changes under light microscopy of the pancreas 
3.5.1. Sham-operated group 
3.5.1.1. Gross pathological changes: except that there was a small amount of light yellow ascites present in the abdominal 
cavity, no other obvious pathological changes were observed. The pancreas showed intact structure and light yellow color. 
At all time points after operation, no obvious abnormality was seen in the pancreas as well as peripancreatic fat and 
omenta. 
3.5.1.2. Pathological changes under light microscopy: the pancreas was normal in most rats and showed intact structure. 
Mild interstitial edema was seen in few cases. Inflammatory cell infiltration was occasionally viewed. 
3.5.2. Model control group 
3.5.2.1. Gross pathological changes: five minutes after operation, the pancreas showed extensive subcapsular hemorrhage 
and necrosis, particularly prominent in the pancreatic tail. At three hours after operation, pancreatic congestion and edema, 
some of which showed jelly-like hemorrhage or necrosis, were obviously seen; a small amount of light red ascites was 
present. At 6 and 12 hours after operation, the pancreas showed extensive congestion and necrosis as well as obvious 
edema; a moderate number of saponified spots were visible in peripancreatic epiploon and peritoneum; a large amount of 
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light red or red bloody ascites was present in the abdominal cavity. 
3.5.2.2. Pathological changes under light microscopy: interstitial edema, few focal or lytic necrotic spots and 
inflammatory cell infiltration were present in the pancreatic head; the pancreatic tail showed more obvious interstitial 
edema, larger focal or lytic necrotic spots as well as more severe inflammatory cell infiltration; the extent and scope of the 
necrosis in the pancreatic tail were more significant than those in the pancreatic head; the pathological changes were 
aggravated with the increase of postoperative duration. 
3.5.3. Baicalin treated group: 
3.5.3.1. Gross pathological changes: at 3 hours after operation, the pancreas showed congestion and necrosis; the 
hemorrhage was milder than that in model control group. At 6 and 12 hours after operation, the scope of hemorrhage in the 
pancreas was relatively restricted; the extent of pancreatic edema and necrosis was milder than that in model control group; 
the majority of ascites became slightly bloody; the amount of ascites was obviously lower than that in model control group; 
the number and density of saponified spots also decreased. 
3.5.3.2. Pathological changes under light microscopy: patchy necrosis still could be seen in the pancreas but was 
distributed in a smaller area; the cellular structure in the pancreas was clearer than that in model control group; the extent of 
interstitial red blood cell exudation, edema and inflammatory cell infiltration was mitigated. 
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4. Discussion 
SAP is an acute abdomen characterized by dangerous clinical manifestations and high mortality rate [5-7]. In recent 
years, some studies have found that, during the development and progression of SAP, the premature activation of pancreatic 
enzymes in acinar cells and excessive inflammatory reaction can induce the production of a large number of cytokines and 
vasoactive substances that are able to, directly or indirectly, give rise to the decrease in local blood flow, blood flow 
velocity, leukocyte adhesion and capillary density as well as the increase in capillary permeability, thereby inducing 
microcirculation disturbance [8, 9]. In turn, microcirculation disturbance is one of the important factors that can induce the 
production of inflammatory mediators. Thus, both microcirculation disturbance and inflammatory mediators serve as 
causes and effects working to form the viscous cycle [10]. For these reasons, it is of important significance to improve 
microcirculation disturbance and reduce inflammatory mediator-induced damage in the therapy of SAP. 
Baicalin, the main effective ingredient of scutellaria baicalensis georgi, can be administered via veins and is very 
cheap. It has antibacterial and anti-inflammatory effects, and is able to inhibit platelet aggregation, scavenge oxygen free 
radicals, suppress thrombin-induced transformation of fibrinogen into fibrin, decrease the production of endotoxin and 
prevent endotoxemia-induced DIC. Moreover, baicalein, the metabolite of Baicalin, shows strong effect in suppressing the 
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activities of pancreatic enzymes [11]. These pharmacological effects, similar to those of octreotide (a somatostatin 
analogue), can block the development of SAP in many aspects. Since the pharmacological effects of Baicalin are even more 
diverse, it is theoretically feasible to treat SAP with Baicalin. 
When SAP develops, PAF can not only induce a series of inflammatory reactions through acting upon leukocytes but 
also cause pancreatic microcirculation disturbance through increasing vascular permeability [12, 13]. In this study, we 
found that, at all time points after operation in model control group and at 6 and 12 hours after operation in Baicalin treated 
group, the contents of PAF were significantly higher than those in sham-operated group (P<0.001 for all), indicating that 
the development of SAP can enhance the release of PAF and thereby induce microcirculation disturbance. We also found 
that, at 6 and 12 hours after operation in Baicalin treated group, the contents of PAF were significantly lower than those in 
model control group, suggesting that Baicalin is able to lower the levels of PAF and thereby improve microcirculation 
disturbance. However, no statistically significant difference was observed because sample size was too small, suggesting 
that Baicalin has a weak effect in lowering the levels of PAF. 
The leukocyte-endothelial cell interactions and microcirculation alterations are two crucial factors that are responsible 
for the development of SAP [14], during which phospholipase A2 (PLA2), whose levels can be used as a marker for 
evaluation of the severity of SAP, plays an important role. When SAP develops, the level of PLA2 rises abnormally, thus 
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accelerating the synthesis of arachidonic acid and inducing the production of large amounts of thromboxane A2 (TXA2) and 
prostaglandin E2 (PGE2). TXA2 can potently contract blood vessels, promote platelet aggregation, recruit leukocytes and 
increase microvascular permeability [15]. Because TXA2 is degraded rapidly, TXB2 as a stable metabolite of TXA2 is 
usually detected to reflect the levels of TXA2. PGE2, secreted by endothelial cells, is able to expand capillary, increase 
blood supply to tissues, protect cells and thereby antagonize the effect of TXA2. In this study, correlation test showed that 
there was a negative correlation between the contents of amylase and PGE2 (R=-0.678, P<0.05). The imbalance in the ratio 
between the levels of TXB2 and PGE2 has more severe effects than the alteration of only one factor. In SAP, the dysfunction 
of the arachidonic acid metabolic network can upregulate the levels of TXB2. As a consequence, the imbalance in the ratio 
between the levels of TXB2 and PGE2 can promote platelet aggregation and thrombosis [16, 17], and thereby induce 
microcirculation disturbance as well as pancreatic and extrapancreatic ischemia and necrosis. Most researchers believe that 
the increase in the levels of blood TXB2 or the ratio between the levels of TXB2 and PGE2 may promote the progression of 
SAP. In this study, we found that the levels of TXB2 and PGE2 in model control group were higher than those in 
sham-operated group. Moreover, the elevating amplitude of TXB2 level was much greater than that of PGE2 level, thereby 
causing the imbalance in the ratio between them and aggravating organ injury. Considering that Baicalin could decrease the 
ratio between the levels of TXB2 and PGE2, it could therefore improve pancreatic injury.  
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IL-1β is able to activate neutrophils and induce microcirculatory thrombosis and tissue injury. Some experiments 
have proved that the contents of IL-1β are positively correlated with the mortality rates of rats [18]. Paszkowski et al. 
[19,20] have found that IL-1β mRNA is expressed in normal lung tissues. In SAP, the expression of IL-1β mRNA is 
significantly enhanced, and the expression levels of IL-1β mRNA are parallel to the severity of SAP. In the present study, 
our results showed that, at all time points after operation, the contents of IL-1β in model control group were significantly 
higher than those in sham-operated group (P<0.001), and the levels of IL-1β are positively correlated with the severity of 
the pathological damage of the pancreas. After treatment with Baicalin, the contents of serum IL-1β in treated group were 
significantly lower than those in model control group (P<0.01 or P<0.001) at 3 and 6 hours after operation. Moreover, the 
pathological damage of the pancreas was mitigated. These results indicate that Baicalin is able to lower the contents of 
IL-1β in SAP rats and have therapeutic effect on SAP. 
Numerous studies have shown that the levels of the above-mentioned inflammatory mediators are upregulated in most 
cases of SAP and can be used as important parameters for evaluation of the severity and prognosis of SAP [21-26], which is 
consistent with the results obtained in this study. The levels of these inflammatory mediators and pancreatic pathological 
scores in Baicalin treated group were obviously lower than those in model control group, suggesting that Baicalin is able to 
lower the levels of inflammatory mediators and mitigate the pathological damage of the pancreas. 
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Blood viscosity test is one of the most direct and convenient ways to study microcirculation. In the present study, we 
found that the high-shear whole blood viscosity, whole blood viscosity and low-shear (1 or 5/s) whole blood viscosity 
(mPa.s) in model control group were significantly higher than those in sham-operated group (P<0.01 or P<0.001), 
indicating that SAP model rats induced with sodium taurocholate showed obvious hemorheological abnormalities, which 
were mainly manifested as an obvious increase in erythrocyte aggregation index, viscous component, elastic component 
and elastic modulus of the peripheral blood at low shear rates, strong RBC aggregation and a decrease in the deformability 
of cells. These changes were gradually aggravated with the progression of the disease [27]. We also found that the pancreas 
of rats in model control group showed hemorrhage and necrosis, and a moderate number of saponified spots were visible in 
peripancreatic epiploon and peritoneum. After treatment with Baicalin, blood viscosity was obviously improved, the scope 
of pancreatic hemorrhage and necrosis was relatively limited, and the number of saponified spots decreased. These results 
suggest that Baicalin could mitigate the pathological injury present in SAP through improving the hemorheology of rats. 
When SAP develops, microcirculation disturbance can induce the increase of pancreatic capillary permeability, thereby 
causing hemorheological changes such as hemoconcentration, the increase in hematocrit and blood viscosity, etc. [28]. In 
this study, at all time points after operation, blood viscosity parameters determined in model control group were obviously 
greater than those in sham-operated group (P<0.01 or P<0.001), indicating that hemorheological abnormality and 
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microcirculation disturbance are present in SAP. These abnormal alterations can induce the damage of vascular endothelial 
cells, increase the resistance of blood flow, promote the stagnation of blood flow and thrombosis, and result in hypoxia and 
cell damage, thereby aggravating the disease. After treatment with Baicalin, blood viscosity was obviously improved, 
suggesting that Baicalin is able to improve microcirculation. At present, no reports on the effect of Baicalin in improving 
blood viscosity are seen in domestic or foreign literature. 
To sum up, the release of a large number of inflammatory mediators and various active substances in SAP could 
induce the morphological alterations and functional disturbance of blood vessels and blood flow. In this study, our results 
shows that Baicalin can exert therapeutic effects on SAP through reducing the mortality rates of SAP rats, lowering the 
contents of inflammatory mediators and active substances in blood, improving microcirculation and mitigating pancreatic 
injury. Therefore, Baicalin, as a new drug, has good prospects in the treatment of SAP. 
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Table 1  Comparision of pathological scores, PAF, amylase, TXB2, PGE2  IL-1β and ascites/body weight ratio ( ( )RM Q ) 
Sham-operated group  Model control group  Baicalin treated group Indexes 
3h 6h 12h  3h 6h 12h  3h 6h 12h 
pathological 
scores  
0.00 
(0.00) 
0.00 
(0.00) 
0.00 
(0.00) 
 
 
7.00*** 
(3.00)  
7.00*** 
(3.00)  
10.00 *** 
(2.00) 
 
 
6.00*** 
(2.00)  
6.00 *** 
(2.00) 
8.50***++ 
(2.00)  
ascites/body 
weight ratio 
0.35 
(0.14) 
0.40 
(0.23) 
0.39 
(0.20) 
 
 
2.17 *** 
(1.04) 
3.20 *** 
(1.03) 
3.26 *** 
(1.12) 
 
 
1.72***+ 
(0.71)  
1.83***+++ 
(0.96)  
2.60***+ 
(1.33)  
amylase 1460 
(579) 
1648 
(493) 
1714 
(286) 
 
 
5675*** 
(1243)  
6632*** 
(3121)  
10164*** 
(3752)  
 
 
4878***+ 
(1723)  
4973*** 
(3380)  
7899***++ 
(1002)  
IL-1β 5.32 
(1.51) 
4.51 
(1.88) 
5.31 
(1.53) 
 28.42*** 
(13.26)  
29.15*** 
(9.63)  
19.33*** 
(16.86)  
 20.39***++ 
(11.28)  
18.26***+++ 
(6.95)  
16.15*** 
(7.70)  
PAF 2.01 
(0.89) 
2.39 
(0.68) 
2.86 
(0.50) 
 
 
8.53*** 
(5.29)  
9.94*** 
(8.53)  
10.06*** 
(7.47)  
 
 
8.29*** 
(3.62)  
7.39*** 
(3.24)  
9.30*** 
(3.19)  
TXB2 74367 
(28685) 
81460 
(70585) 
75891 
(64452) 
 
 
444864 *** 
(459803) 
387872*** 
(336106)  
330079 *** 
(365180) 
 
 
411537*** 
(255318)  
233710 ***+ 
(237615) 
334108*** 
(202589)  
PGE2 7349 
(4221) 
6994 
(5715) 
7485 
(4555) 
 
 
27628*** 
(5435)  
27125 *** 
(6257) 
28125*** 
(16993)  
 
 
29017*** 
(7143)  
29910*** 
(15511)  
29451*** 
(8929)  
Note: compare to sham-operated group,* P<0.05,**P<0.01,***P<0.001;  compare to model control group, +P<0.05,++P<0.01,+++P<0.001 
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Table 2  Comparision of  PLA2 among groups ( X S± ) 
Groups 3h 6h 12h 
Sham-operated group 14.62±3.02 17.49±3.82 19.02±5.07 
Model control group 76.09±16.70 101.46±14.67* 105.33±18.10* 
Baicalin treated group 56.25±22.43 67.91±20.61*+ 66.86±22.10*+ 
Note: compare to sham-operated group, *P<0.001;  compare to model control group,+ P<0.001 
 
Table 3  Comparison of blood viscosity parameters  ( X S± ) 
Sham-operated group Model control group    Baicalin treated group Indexes 
3h 12h 3h 12h 3h 12h 
high-shear whole blood viscosity 
(200/s) (mPa.s) 2.88±0.53 2.98±0.55 4.12±0.73** 4.69±0.72*** 3.60±1.32 3.80±0.77**++ 
whole blood viscosity (30/s)(mPa.s) 
4.21±0.88 4.84±0.91 6.18±1.10*** 7.03±1.53*** 5.42±1.75* 5.51±1.44 
low-shear whole blood viscosity 
(5/s)(mPa.s) 
7.48±1.27 8.12±1.69 11.54±3.34*** 11.57±2.42 9.54±2.17 10.65±3.40* 
low-shear whole blood viscosity 
(1/s)(mPa.s) 
13.28±2.83 16.14±3.16 32.07±12.23*** 30±8.65*** 20.83±5.68*++ 21.67±6.31++ 
Note: compare to sham-operated group, * P<0.05, **P<0.01, ***P<0.001;  compare to model control group, +P<0.05,++P<0.01,+++P<0.001 
